[go: up one dir, main page]

DE69408394D1 - 4-Piperidino-piperidin zur Behandlung von Tumoren - Google Patents

4-Piperidino-piperidin zur Behandlung von Tumoren

Info

Publication number
DE69408394D1
DE69408394D1 DE69408394T DE69408394T DE69408394D1 DE 69408394 D1 DE69408394 D1 DE 69408394D1 DE 69408394 T DE69408394 T DE 69408394T DE 69408394 T DE69408394 T DE 69408394T DE 69408394 D1 DE69408394 D1 DE 69408394D1
Authority
DE
Germany
Prior art keywords
piperidino
piperidine
tumors
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69408394T
Other languages
English (en)
Other versions
DE69408394T2 (de
Inventor
Masao Oguro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE69408394D1 publication Critical patent/DE69408394D1/de
Publication of DE69408394T2 publication Critical patent/DE69408394T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69408394T 1993-10-29 1994-10-27 4-Piperidino-piperidin zur Behandlung von Tumoren Expired - Fee Related DE69408394T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5271769A JPH07126165A (ja) 1993-10-29 1993-10-29 腫瘍治療剤

Publications (2)

Publication Number Publication Date
DE69408394D1 true DE69408394D1 (de) 1998-03-12
DE69408394T2 DE69408394T2 (de) 1998-06-18

Family

ID=17504595

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69408394T Expired - Fee Related DE69408394T2 (de) 1993-10-29 1994-10-27 4-Piperidino-piperidin zur Behandlung von Tumoren

Country Status (5)

Country Link
US (1) US5569471A (de)
EP (1) EP0650726B1 (de)
JP (1) JPH07126165A (de)
CA (1) CA2134194A1 (de)
DE (1) DE69408394T2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6305923B1 (en) * 1998-06-12 2001-10-23 Husky Injection Molding Systems Ltd. Molding system using film heaters and/or sensors
EP1676845B1 (de) 1999-11-05 2008-06-11 AstraZeneca AB Neue Quinazolin-Derivate
ES2518926T3 (es) * 2000-06-02 2014-11-05 Board Of Regents, The University Of Texas System Conjugados de etilendicisteína y un análogo de glucosa
US6376514B1 (en) 2000-10-17 2002-04-23 The Procter & Gamble Co. Substituted six-membered heterocyclic compounds useful for treating multidrug resistance and compositions and methods thereof
US6693099B2 (en) 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
KR20030066927A (ko) * 2002-02-06 2003-08-14 구자영 쿠르쿠민과 5-프루오로유라실로 이루어진 항암제 및 이항암제의 용도
US10925977B2 (en) 2006-10-05 2021-02-23 Ceil>Point, LLC Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07116146B2 (ja) * 1986-12-05 1995-12-13 広栄化学工業株式会社 ４−ピペリジノピペリジン類の製造法

Also Published As

Publication number Publication date
DE69408394T2 (de) 1998-06-18
CA2134194A1 (en) 1995-04-30
EP0650726A1 (de) 1995-05-03
EP0650726B1 (de) 1998-02-04
US5569471A (en) 1996-10-29
JPH07126165A (ja) 1995-05-16

Similar Documents

Publication Publication Date Title
DE122009000012I1 (de) Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen.
EP0709090A3 (de) Zusammensetzungen zur Behandlung von resistenten Tumoren
DE69427869D1 (de) Botulinumtoxine zur behandlung von hyperhydrosis
DE69821667D1 (de) Kardioverter zur Behandlung von Vorhofflattern
DE69307509D1 (de) Vorrichtung zur behandlung von herzfehlern
DE69206341D1 (de) Verfahren zur Behandlung von BCTMP/CTMP-Abwasser.
DE69412552D1 (de) Medizinisches Instrument zur Behandlung von Sinusitis
DE69224080D1 (de) Verwendung von nsaid zur behandlung von demenz
ATE235236T1 (de) Unsubstituierte polydiallylaminen zur behandlung von hypercholesterolemia
DE69318693D1 (de) Magnetischer Konditionierer zur Behandlung von Flüssigkeiten
DE69732152D1 (de) Vorrichtung zur Behandlung von Kopfschmerzen
DE3870508D1 (de) Zusammensetzung zur behandlung des haares.
ATE267180T1 (de) Phosphorderivate zur behandlung von aids
DE69019345D1 (de) Zusammensetzung zur behandlung von samen.
DE69635708D1 (de) Tetrandrin zur behandlung von augenentzündungen
DE69423131D1 (de) Verfahren zur Behandlung von Mycobakterien enthaltenden Auswürfen
DE3888056D1 (de) Oxadiazolyl-azabicycloheptane zur Behandlung von seniler Demenz.
DE69405919D1 (de) Zusammensetzungen zur Behandlung von Keratinfasern
DE69737067D1 (de) Vakzine zur behandlung von mycosen
DE3869590D1 (de) Mischung zur behandlung von hypercholesterolemie.
DE69807466D1 (de) Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten
DE69420229D1 (de) Pharmazeutische Zusammensetzung zur Behandlung von AIDS
DE69328615D1 (de) Verfahren zur behandlung von viehhaltungsgülle
DE69607559D1 (de) Verfahren zur Behandlung von Phenolteer
DE69834937D1 (de) Antibiotika zur behandlung von magengeschwuren

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee